Glycoprotein Non-Metastatic Protein B (GPNMB): The Missing Link Between Lysosomes and Obesity
Experimental and Clinical Endocrinology & Diabetes · 2023-12 · 131 (12) · 639-645
DOI: 10.1055/a-2192-0101 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, online erschienen am 13.11.2023. Verfasst von Valentina Bianco und 1 weiteren Autor:innen. Beteiligte Einrichtung: Gottfried Schatz Research Center, Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria. Hauptthemen laut MEDLINE: Membrane Glycoproteins, Glycoproteins. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
As a result of an unhealthy diet and limited physical activity, obesity has become a widespread pandemic worldwide and is an important predictor for the development of cardiovascular disease. Obesity is often characterized by a pro-inflammatory environment in white adipose tissue (WAT), mainly due to increased macrophage infiltration. These immune cells boost their lipid concentrations by accumulating the content of dying adipocytes. As the lysosome is highly involved in lipid handling, the progressive lipid accumulation may result in lysosomal stress and a metabolic shift. Recent studies have identified glycoprotein non-metastatic melanoma protein B (GPNMB) as a novel marker of inflammatory diseases. GPNMB is a type I transmembrane protein on the cell surface of various cell types, such as macrophages, dendritic cells, osteoblasts, and microglia, from which it can be proteolytically cleaved into a soluble molecule. It is induced by lysosomal stress via microphthalmia-associated transcription factor and thus has been found to be upregulated in many lysosomal storage disorders. In addition, a clear connection between GPNMB and obesity was recently established. GPNMB was shown to have protective and anti-inflammatory effects in most cases, preventing the progression of obesity-related metabolic disorders. In contrast, soluble GPNMB likely has the opposite effect and promotes lipogenesis in WAT. This review aims to summarize and clarify the role of GPNMB in the progression of obesity and to highlight its potential use as a biomarker for lipid-associated disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Gottfried Schatz Research Center, Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.
- BioTechMed-Graz, Graz, Austria.
ORCID-Profile: Valentina Bianco
Zitieren
APA
Bianco, V., & Kratky, D. (2023). Glycoprotein Non-Metastatic Protein B (GPNMB): The Missing Link Between Lysosomes and Obesity. Experimental and Clinical Endocrinology & Diabetes, 131(12), 639-645. https://doi.org/10.1055/a-2192-0101
Vancouver
Bianco V, Kratky D. Glycoprotein Non-Metastatic Protein B (GPNMB): The Missing Link Between Lysosomes and Obesity. Experimental and Clinical Endocrinology & Diabetes. 2023;131(12):639-645. doi:10.1055/a-2192-0101
BibTeX
@article{Bianco2023,
author = {Bianco, Valentina and Kratky, Dagmar},
title = {Glycoprotein Non-Metastatic Protein B (GPNMB): The Missing Link Between Lysosomes and Obesity},
journal = {Experimental and Clinical Endocrinology & Diabetes},
year = {2023},
volume = {131},
number = {12},
pages = {639--645},
doi = {10.1055/a-2192-0101}
}
EUVIMED